Payments to Acquire Property, Plant, and Equipment of BridgeBio Pharma, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
BridgeBio Pharma, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • BridgeBio Pharma, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • BridgeBio Pharma, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $1,097,000, a 18% increase from 2024.
  • BridgeBio Pharma, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $933,000, a 29% decline from 2023.
  • BridgeBio Pharma, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,306,000, a 73% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

BridgeBio Pharma, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,097,000 +$164,000 +18% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $933,000 -$373,000 -29% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $1,306,000 -$3,515,000 -73% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $4,821,000 -$8,425,000 -64% 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2025 2024 FY
2021 $13,246,000 +$5,728,000 +76% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $7,518,000 +$4,880,000 +185% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $2,638,000 +$460,000 +21% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $2,178,000 +$1,714,000 +369% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $464,000 01 Jan 2017 31 Dec 2017 10-K 03 Mar 2020 2019 FY

BridgeBio Pharma, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$695,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025 2025 Q1
Q1 2024 $695,000 +$683,000 +5692% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025 2025 Q1
Q1 2023 $12,000 -$847,000 -99% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $859,000 -$1,102,000 -56% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $1,961,000 -$2,516,000 -56% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $4,477,000 +$4,050,000 +948% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $427,000 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.